20250179137. Il18 Receptor (Regeneron Pharmaceuticals, .)
IL18 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
Abstract: the present disclosure relates to il18 receptor agonists with improved therapeutic profiles.
Inventor(s): Jiaxi WU, Aaron CHANG, Olivia ANTAO, Eva-Maria WEICK, Amanda DORVILLIERS, Erica ULLMAN
CPC Classification: C07K14/54 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))
Search for rejections for patent application number 20250179137